Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Industry Market Research Report

MAI2859097
108 Pages
January 2019
Pharmaceuticals

Download Sample Get Discount

The Non-Alcoholic Fatty Liver Disease (Nafld) Drug market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Non-Alcoholic Fatty Liver Disease (Nafld) Drug industrial chain, this report mainly elaborate the definition, types, applications and major players of Non-Alcoholic Fatty Liver Disease (Nafld) Drug market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Non-Alcoholic Fatty Liver Disease (Nafld) Drug market.

The Non-Alcoholic Fatty Liver Disease (Nafld) Drug market can be split based on product types, major applications, and important regions.

Major Players in Non-Alcoholic Fatty Liver Disease (Nafld) Drug market are:

Daewoong Pharmaceutical

Tobira Therapeutics

Conatus Pharmaceuticals

Verva Pharmaceuticals

Zafgen

TCM Biotech International

Galmed International

Metabolic Solutions Development

Raptor Pharmaceuticals

Phenex Pharmaceuticals

Kyorin Pharmaceutical

Novartis AG

Major Regions play vital role in Non-Alcoholic Fatty Liver Disease (Nafld) Drug market are:

North America

Europe

China

Japan

Middle East & Africa

India

South America

Others

Most important types of Non-Alcoholic Fatty Liver Disease (Nafld) Drug products covered in this report are:

Type 1

Type 2

Type 3

Type 4

Type 5

Most widely used downstream fields of Non-Alcoholic Fatty Liver Disease (Nafld) Drug market covered in this report are:

Application 1

Application 2

Application 3

Application 4

Application 5

There are 13 Chapters to thoroughly display the Non-Alcoholic Fatty Liver Disease (Nafld) Drug market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Non-Alcoholic Fatty Liver Disease (Nafld) Drug Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Non-Alcoholic Fatty Liver Disease (Nafld) Drug.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Non-Alcoholic Fatty Liver Disease (Nafld) Drug.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Non-Alcoholic Fatty Liver Disease (Nafld) Drug by Regions (2013-2018).

Chapter 6: Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export and Import by Regions (2013-2018).

Chapter 7: Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Non-Alcoholic Fatty Liver Disease (Nafld) Drug.

Chapter 9: Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Analysis and Forecast by Type and Application (2018-2023).

Chapter 10: Market Analysis and Forecast by Regions (2018-2023).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Industry Market Research Report

1 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Introduction and Market Overview

1.1 Objectives of the Study

1.2 Definition of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

1.3 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Scope and Market Size Estimation

1.3.1 Market Concentration Ratio and Market Maturity Analysis

1.3.2 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate from 2013-2023

1.4 Market Segmentation

1.4.1 Types of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

1.4.2 Applications of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

1.4.3 Research Regions

1.4.3.1 North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.2 Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.3 China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.4 Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.5 Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.6 India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.4.3.7 South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

1.5 Market Dynamics

1.5.1 Drivers

1.5.1.1 Emerging Countries of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

1.5.1.2 Growing Market of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

1.5.2 Limitations

1.5.3 Opportunities

1.6 Industry News and Policies by Regions

1.6.1 Industry News

1.6.2 Industry Policies

2 Industry Chain Analysis

2.1 Upstream Raw Material Suppliers of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Analysis

2.2 Major Players of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

2.2.1 Major Players Manufacturing Base and Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug in 2017

2.2.2 Major Players Product Types in 2017

2.3 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Manufacturing Cost Structure Analysis

2.3.1 Production Process Analysis

2.3.2 Manufacturing Cost Structure of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

2.3.3 Raw Material Cost of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

2.3.4 Labor Cost of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

2.4 Market Channel Analysis of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

2.5 Major Downstream Buyers of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Analysis

3 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market, by Type

3.1 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Market Share by Type (2013-2018)

3.2 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Market Share by Type (2013-2018)

3.3 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate by Type (2013-2018)

3.4 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Price Analysis by Type (2013-2018)

4 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market, by Application

4.1 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Market Share by Application (2013-2018)

4.2 Downstream Buyers by Application

4.3 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate by Application (2013-2018)

5 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($) by Region (2013-2018)

5.1 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Market Share by Region (2013-2018)

5.2 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Market Share by Region (2013-2018)

5.3 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.4 North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.5 Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.6 China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.7 Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.8 Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.9 India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

5.10 South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

6 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import by Regions (2013-2018)

6.1 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption by Regions (2013-2018)

6.2 North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.3 Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.4 China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.5 Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.6 Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.7 India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

6.8 South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

7 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis by Regions

7.1 North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.2 Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.3 China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.4 Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.5 Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.6 India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

7.7 South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Status and SWOT Analysis

8 Competitive Landscape

8.1 Competitive Profile

8.2 Daewoong Pharmaceutical

8.2.1 Company Profiles

8.2.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.2.3 Daewoong Pharmaceutical Production, Value ($), Price, Gross Margin 2013-2018E

8.2.4 Daewoong Pharmaceutical Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.3 Tobira Therapeutics

8.3.1 Company Profiles

8.3.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.3.3 Tobira Therapeutics Production, Value ($), Price, Gross Margin 2013-2018E

8.3.4 Tobira Therapeutics Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.4 Conatus Pharmaceuticals

8.4.1 Company Profiles

8.4.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.4.3 Conatus Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

8.4.4 Conatus Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.5 Verva Pharmaceuticals

8.5.1 Company Profiles

8.5.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.5.3 Verva Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

8.5.4 Verva Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.6 Zafgen

8.6.1 Company Profiles

8.6.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.6.3 Zafgen Production, Value ($), Price, Gross Margin 2013-2018E

8.6.4 Zafgen Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.7 TCM Biotech International

8.7.1 Company Profiles

8.7.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.7.3 TCM Biotech International Production, Value ($), Price, Gross Margin 2013-2018E

8.7.4 TCM Biotech International Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.8 Galmed International

8.8.1 Company Profiles

8.8.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.8.3 Galmed International Production, Value ($), Price, Gross Margin 2013-2018E

8.8.4 Galmed International Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.9 Metabolic Solutions Development

8.9.1 Company Profiles

8.9.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.9.3 Metabolic Solutions Development Production, Value ($), Price, Gross Margin 2013-2018E

8.9.4 Metabolic Solutions Development Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.10 Raptor Pharmaceuticals

8.10.1 Company Profiles

8.10.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.10.3 Raptor Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

8.10.4 Raptor Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.11 Phenex Pharmaceuticals

8.11.1 Company Profiles

8.11.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.11.3 Phenex Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

8.11.4 Phenex Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.12 Kyorin Pharmaceutical

8.12.1 Company Profiles

8.12.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.12.3 Kyorin Pharmaceutical Production, Value ($), Price, Gross Margin 2013-2018E

8.12.4 Kyorin Pharmaceutical Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

8.13 Novartis AG

8.13.1 Company Profiles

8.13.2 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Introduction

8.13.3 Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E

8.13.4 Novartis AG Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

9 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Analysis and Forecast by Type and Application

9.1 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) & Volume Forecast, by Type (2018-2023)

9.1.1 Type 1 Market Value ($) and Volume Forecast (2018-2023)

9.1.2 Type 2 Market Value ($) and Volume Forecast (2018-2023)

9.1.3 Type 3 Market Value ($) and Volume Forecast (2018-2023)

9.1.4 Type 4 Market Value ($) and Volume Forecast (2018-2023)

9.1.5 Type 5 Market Value ($) and Volume Forecast (2018-2023)

9.2 Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) & Volume Forecast, by Application (2018-2023)

9.2.1 Application 1 Market Value ($) and Volume Forecast (2018-2023)

9.2.2 Application 2 Market Value ($) and Volume Forecast (2018-2023)

9.2.3 Application 3 Market Value ($) and Volume Forecast (2018-2023)

9.2.4 Application 4 Market Value ($) and Volume Forecast (2018-2023)

9.2.5 Application 5 Market Value ($) and Volume Forecast (2018-2023)

10 Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Analysis and Forecast by Region

10.1 North America Market Value ($) and Consumption Forecast (2018-2023)

10.2 Europe Market Value ($) and Consumption Forecast (2018-2023)

10.3 China Market Value ($) and Consumption Forecast (2018-2023)

10.4 Japan Market Value ($) and Consumption Forecast (2018-2023)

10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2018-2023)

10.6 India Market Value ($) and Consumption Forecast (2018-2023)

10.7 South America Market Value ($) and Consumption Forecast (2018-2023)

11 New Project Feasibility Analysis

11.1 Industry Barriers and New Entrants SWOT Analysis

11.2 Analysis and Suggestions on New Project Investment

12 Research Finding and Conclusion

13 Appendix

13.1 Discussion Guide

13.2 Knowledge Store: Maia Subscription Portal

13.3 Research Data Source

13.4 Research Assumptions and Acronyms Used

List of Tables and Figures

Figure Product Picture of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Table Product Specification of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Market Concentration Ratio and Market Maturity Analysis of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate from 2013-2023

Table Different Types of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Segment by Type from 2013-2018

Figure Non-Alcoholic Fatty Liver Disease (Nafld) Drug Type 1 Picture

Figure Non-Alcoholic Fatty Liver Disease (Nafld) Drug Type 2 Picture

Figure Non-Alcoholic Fatty Liver Disease (Nafld) Drug Type 3 Picture

Figure Non-Alcoholic Fatty Liver Disease (Nafld) Drug Type 4 Picture

Figure Non-Alcoholic Fatty Liver Disease (Nafld) Drug Type 5 Picture

Table Different Applications of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Segment by Applications from 2013-2018

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Figure Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Value ($) and Growth Rate (2013-2018)

Table Emerging Countries of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Table Growing Market of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Industry Chain Analysis of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Table Upstream Raw Material Suppliers of Non-Alcoholic Fatty Liver Disease (Nafld) Drug with Contact Information

Table Major Players Manufacturing Base and Market Share ($) of Non-Alcoholic Fatty Liver Disease (Nafld) Drug in 2017

Table Major Players Non-Alcoholic Fatty Liver Disease (Nafld) Drug Product Types in 2017

Figure Production Process of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Manufacturing Cost Structure of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Figure Channel Status of Non-Alcoholic Fatty Liver Disease (Nafld) Drug

Table Major Distributors of Non-Alcoholic Fatty Liver Disease (Nafld) Drug with Contact Information

Table Major Downstream Buyers of Non-Alcoholic Fatty Liver Disease (Nafld) Drug with Contact Information

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) by Type (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Share by Type (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Share by Type (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production by Type (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Share by Type (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Share by Type (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate of Type 1

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate of Type 2

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate of Type 3

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate of Type 4

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) and Growth Rate of Type 5

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Price by Type (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption by Application (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption Market Share by Application (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption Market Share by Application (2013-2018)

Table Downstream Buyers Introduction by Application

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate of Application 1 (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate of Application 2 (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate of Application 3 (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate of Application 4 (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate of Application 5 (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) by Region (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Market Share by Region (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Value ($) Market Share by Region (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production by Region (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Market Share by Region (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production Market Share by Region (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Value ($), Price and Gross Margin (2013-2018)

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption by Regions (2013-2018)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption Share by Regions (2013-2018)

Table North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Table South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production, Consumption, Export, Import (2013-2018)

Figure North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure North America Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure Europe Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure China Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure China Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure Japan Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure Middle East & Africa Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure India Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure India Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Production and Growth Rate Analysis

Figure South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug Consumption and Growth Rate Analysis

Figure South America Non-Alcoholic Fatty Liver Disease (Nafld) Drug SWOT Analysis

Figure Top 3 Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Companies

Figure Top 6 Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Companies

Table Mergers, Acquisitions and Expansion Analysis

Table Company Profiles

Table Product Introduction

Table Daewoong Pharmaceutical Production, Value ($), Price, Gross Margin 2013-2018E

Figure Daewoong Pharmaceutical Production and Growth Rate

Figure Daewoong Pharmaceutical Value ($) Market Share 2013-2018E

Figure Daewoong Pharmaceutical Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Tobira Therapeutics Production, Value ($), Price, Gross Margin 2013-2018E

Figure Tobira Therapeutics Production and Growth Rate

Figure Tobira Therapeutics Value ($) Market Share 2013-2018E

Figure Tobira Therapeutics Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Conatus Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

Figure Conatus Pharmaceuticals Production and Growth Rate

Figure Conatus Pharmaceuticals Value ($) Market Share 2013-2018E

Figure Conatus Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Verva Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

Figure Verva Pharmaceuticals Production and Growth Rate

Figure Verva Pharmaceuticals Value ($) Market Share 2013-2018E

Figure Verva Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Zafgen Production, Value ($), Price, Gross Margin 2013-2018E

Figure Zafgen Production and Growth Rate

Figure Zafgen Value ($) Market Share 2013-2018E

Figure Zafgen Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table TCM Biotech International Production, Value ($), Price, Gross Margin 2013-2018E

Figure TCM Biotech International Production and Growth Rate

Figure TCM Biotech International Value ($) Market Share 2013-2018E

Figure TCM Biotech International Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Galmed International Production, Value ($), Price, Gross Margin 2013-2018E

Figure Galmed International Production and Growth Rate

Figure Galmed International Value ($) Market Share 2013-2018E

Figure Galmed International Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Metabolic Solutions Development Production, Value ($), Price, Gross Margin 2013-2018E

Figure Metabolic Solutions Development Production and Growth Rate

Figure Metabolic Solutions Development Value ($) Market Share 2013-2018E

Figure Metabolic Solutions Development Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Raptor Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

Figure Raptor Pharmaceuticals Production and Growth Rate

Figure Raptor Pharmaceuticals Value ($) Market Share 2013-2018E

Figure Raptor Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Phenex Pharmaceuticals Production, Value ($), Price, Gross Margin 2013-2018E

Figure Phenex Pharmaceuticals Production and Growth Rate

Figure Phenex Pharmaceuticals Value ($) Market Share 2013-2018E

Figure Phenex Pharmaceuticals Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Kyorin Pharmaceutical Production, Value ($), Price, Gross Margin 2013-2018E

Figure Kyorin Pharmaceutical Production and Growth Rate

Figure Kyorin Pharmaceutical Value ($) Market Share 2013-2018E

Figure Kyorin Pharmaceutical Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Company Profiles

Table Product Introduction

Table Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Value ($) Market Share 2013-2018E

Figure Novartis AG Market Share of Non-Alcoholic Fatty Liver Disease (Nafld) Drug Segmented by Region in 2017

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) Forecast, by Type

Table Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume Forecast, by Type

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) and Growth Rate Forecast of Type 1 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume and Growth Rate Forecast of Type 1 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) and Growth Rate Forecast of Type 2 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume and Growth Rate Forecast of Type 2 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) and Growth Rate Forecast of Type 3 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume and Growth Rate Forecast of Type 3 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) and Growth Rate Forecast of Type 4 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume and Growth Rate Forecast of Type 4 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Value ($) and Growth Rate Forecast of Type 5 (2018-2023)

Figure Global Non-Alcoholic Fatty Liver Disease (Nafld) Drug Market Volume and Growth Rate Forecast of Type 5 (2018-2023)

Table Global Market Value ($) Forecast by Application (2018-2023)

Table Global Market Volume Forecast by Application (2018-2023)

Figure Market Value ($) and Growth Rate Forecast of Application 1 (2018-2023)

Figure Market Volume and Growth Rate Forecast of Application 1 (2018-2023)

Figure Market Value ($) and Growth Rate Forecast of Application 2 (2018-2023)

Figure Market Volume and Growth Rate Forecast of Application 2 (2018-2023)

Figure Market Value ($) and Growth Rate Forecast of Application 3 (2018-2023)

Figure Market Volume and Growth Rate Forecast of Application 3 (2018-2023)

Figure Market Value ($) and Growth Rate Forecast of Application 4 (2018-2023)

Figure Market Volume and Growth Rate Forecast of Application 4 (2018-2023)

Figure Market Value ($) and Growth Rate Forecast of Application 5 (2018-2023)

Figure Market Volume and Growth Rate Forecast of Application 5 (2018-2023)

Figure North America Market Value ($) and Growth Rate Forecast (2018-2023)

Table North America Consumption and Growth Rate Forecast (2018-2023)

Figure Europe Market Value ($) and Growth Rate Forecast (2018-2023)

Table Europe Consumption and Growth Rate Forecast (2018-2023)

Figure China Market Value ($) and Growth Rate Forecast (2018-2023)

Table China Consumption and Growth Rate Forecast (2018-2023)

Figure Japan Market Value ($) and Growth Rate Forecast (2018-2023)

Table Japan Consumption and Growth Rate Forecast (2018-2023)

Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2018-2023)

Table Middle East & Africa Consumption and Growth Rate Forecast (2018-2023)

Figure India Market Value ($) and Growth Rate Forecast (2018-2023)

Table India Consumption and Growth Rate Forecast (2018-2023)

Figure South America Market Value ($) and Growth Rate Forecast (2018-2023)

Table South America Consumption and Growth Rate Forecast (2018-2023)

Figure Industry Resource/Technology/Labor Importance Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery